Intellectus Partners, LLC Abb Vie Inc. Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 6,131 shares of ABBV stock, worth $1.08 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

6,131

Previous 10,539 41.83%

Holding current value

$1.08 Million

Previous $1.81 Million 33.04%

% of portfolio

0.32%

Previous 0.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$163.84 - $199.33 $722,206 - $878,646	-4,408 Reduced 41.83%	6,131 $1.21 Million
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $763,269 - $891,327	4,931 Added 87.93%	10,539 $1.81 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $1.15 Million - $1.31 Million	-7,187 Reduced 56.17%	5,608 $1.02 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $5,091 - $5,733	-37 Reduced 0.29%	12,795 $1.98 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $1,736 - $2,010	-13 Reduced 0.1%	12,832 $1.91 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $3,577 - $4,452	27 Added 0.21%	12,845 $1.73 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $231,086 - $266,130	1,598 Added 14.24%	12,818 $2.04 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $8,021 - $9,620	58 Added 0.52%	11,220 $1.81 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $46,436 - $53,259	-346 Reduced 3.01%	11,162 $1.5 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $110,096 - $139,968	-800 Reduced 6.5%	11,508 $1.76 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $375,483 - $465,868	2,845 Added 30.06%	12,308 $2 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $2,148 - $2,718	-20 Reduced 0.21%	9,463 $1.28 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $18,407 - $20,894	173 Added 1.86%	9,483 $1.02 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $533,940 - $594,840	5,075 Added 119.83%	9,310 $1.05 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $817,786 - $900,284	-7,994 Reduced 65.37%	4,235 $458,000
Q4 2020 Feb 18, 2021	BUY	$80.49 - $108.67 $980,046 - $1.32 Million	12,176 Added 22973.58%	12,229 $1.31 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $1.03 Million - $1.39 Million	-12,836 Reduced 99.59%	53 $1.31 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $170,445 - $200,046	-1,984 Reduced 13.34%	12,889 $1.13 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.09 Million - $1.46 Million	14,873 New	14,873 $1.46 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $786,319 - $1.19 Million	-12,191 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $29,140 - $36,461	404 Added 3.43%	12,191 $1.08 Million
Q3 2019 Oct 11, 2019	BUY	$62.98 - $75.72 $145,672 - $175,140	2,313 Added 24.41%	11,787 $893,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $78,840 - $100,776	1,200 Added 14.5%	9,474 $689,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $125,352 - $147,533	1,625 Added 24.44%	8,274 $667,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $62,513 - $77,096	-803 Reduced 10.78%	6,649 $613,000
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $57,880 - $64,344	651 Added 9.57%	7,452 $705,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $105,491 - $124,820	1,175 Added 20.89%	6,801 $630,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $396,931 - $531,527	4,314 Added 328.81%	5,626 $533,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,312	1,312 $95,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Abb Vie Inc. Transaction History